Informatie:
Fout:
ID
34232
Beschrijving
POLish Bifurcation Optimal Stenting Study; ODM derived from: https://clinicaltrials.gov/show/NCT02192840
Link
https://clinicaltrials.gov/show/NCT02192840
Trefwoorden
Versies (1)
- 15-01-19 15-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
15 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Coronary Artery Disease NCT02192840
Eligibility Coronary Artery Disease NCT02192840
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT02192840
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
subject able to verbally confirm understandings of risks, benefits of receiving pci for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
ID.2
Item
target main branch lesion(s) located in a native coronary artery with diameter of ≥
boolean
ID.3
Item
2.5 mm and ≤ 4.5 mm. target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
boolean
ID.4
Item
target lesion(s) amenable for pci with balloon angioplasty of the side branch.
boolean
ID.5
Item
stemi
boolean
ID.6
Item
non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
boolean
ID.7
Item
subjects who refuse to give informed consent.
boolean
ID.8
Item
subjects with lvef<30%
boolean
ID.9
Item
subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy
boolean